Implant Surface Characteristics Modulate Differentiation Behavior of Cells in the Osteoblastic Lineage

Advances in dental research - Tập 13 Số 1 - Trang 38-48 - 1999
Zvi Schwartz1, Christoph H. Lohmann2, J. Oefinger3, Lynda F. Bonewald4, David D. Dean3, Barbara D. Boyan3
1Department of Orthopaedics, Hebrew University Jerusalem, Israel
2Department of Orthopaedics, University of Gottingen, Germany
3Department of Orthopaedics,
4Department of Medicine/Endocrinology University of Texas Health Science Center at San Antonio 7703 Floyd Curl Drive San Antonio, Texas 78284-7774, USA

Tóm tắt

This paper reviews the role of surface roughness in the osteogenic response to implant materials. Cells in the osteoblast lineage respond to roughness in cell-maturation-specific ways, exhibiting surface-dependent morphologies and growth characteristics. MG63 cells, a human osteoblast-like osteosarcoma cell line, respond to increasing surface roughness with decreased proliferation and increased osteoblastic differentiation. Alkaline phosphatase activity and osteocalcin production are increased. Local factor production is also affected; production of both TGF-β1 and PGE2 is increased. On rougher surfaces, MG63 cells exhibit enhanced responsiveness to 1,25-(OH)2D3. Prostaglandins mediate the effects of surface roughness, since indomethacin prevents the increased expression of differentiation markers in these cells.

Từ khóa


Tài liệu tham khảo

10.1016/0304-4165(95)00182-4

Akiyama SK, 1996, Human Cell, 9, 181

10.1096/fasebj.4.11.2199285

10.3109/17453678108991776

Anderson HC (1984). Matrix vesicle calcification: review and update . In: Bone and mineral research. Pick WA, editor. Amsterdam: Excerpta Medica, pp. 109-149.

10.1002/(SICI)1097-4636(19980905)41:3<489::AID-JBM20>3.0.CO;2-C

10.1016/0169-6009(91)90100-E

Bobyn JD, 1980, Clin Orthop, 149, 291, 10.1097/00003086-198006000-00040

Bodine RL, 1970, Dent Clin North Am, 14, 145, 10.1016/S0011-8532(22)01850-X

10.3181/00379727-200-43410A

Bonewald LF, 1990, Clin Orthop Rel Res, 250, 261, 10.1097/00003086-199001000-00036

10.1002/jcp.1041450203

10.1210/mend-5-6-741

Bonewald LF, 1992, J Biol Chem, 267, 8943, 10.1016/S0021-9258(19)50371-4

Boyan BD, 1989, J Biol Chem, 264, 11879, 10.1016/S0021-9258(18)80148-X

Boyan BD, 1994, J Biol Chem, 269, 28374, 10.1016/S0021-9258(18)46938-4

10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L

Branemark P-I (1985). Tissue integrated prosthesis osteointegration in clinical dentistry. In: Tissue-integrated prostheses: osseointergration in clinical dentistry. Branemark P-I., Zarb GA, Albrektsson T., editors. Chicago, IL: Quintessence Publishing Co., pp. 11-76.

10.1034/j.1600-0501.1995.060101.x

10.1002/jbmr.5650090609

10.1016/0014-4827(86)90217-X

Brunette DM, 1988, Int J Oral Maxillofac Implants, 3, 231

Brunette DM, Ratkay J., Chehroudi B. (1991). The behavior of osteoblasts on micromachined surfaces . In: Bone-biomaterials interface. Davies JE, editor. Toronto: University of Toronto Press, pp. 170-179.

10.1002/jcp.1041400319

Caplan AI, Boyan BD (1994). Endochondral bone formation: the lineage cascade . In: Bone 8. Mechanisms of bone development and growth. Hall BK, editor. Boca Raton: CRC Press, pp. 1-46.

10.1002/jbm.820230907

10.1002/jbm.820240906

Chen D., 1995, Mol Cell Differentiation, 3, 193

10.1038/33719

10.1034/j.1600-0501.1996.070306.x

10.1083/jcb.131.2.539

10.1006/excr.1996.0306

10.2106/00004623-199072090-00016

10.1016/0142-9612(96)87281-4

10.1093/rheumatology/36.7.729

10.1002/jor.1100140606

10.1016/0022-3913(83)90175-0

10.1177/00220345790580024701

10.1016/0142-9612(93)90172-X

10.1002/jbm.820070304

10.1016/0142-9612(95)93256-D

10.1111/j.1432-1033.1994.tb19989.x

Jarcho M., 1977, J Bioengineering, 1, 79

10.1016/0022-3913(83)90359-1

10.1359/jbmr.1997.12.12.2014

10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O

10.1002/jbm.820281206

10.1016/0003-9861(91)90141-5

10.1016/S0142-9612(98)00144-6

Loechler PS, 1952, Northwest Dent, 31, 134

10.1002/jbm.820290314

10.1034/j.1600-0501.1996.070104.x

10.1002/(SICI)1097-4636(199805)40:2<171::AID-JBM1>3.0.CO;2-I

10.1002/jcb.240560221

Miyazono K., 1988, J Biol Chem, 263, 6407, 10.1016/S0021-9258(18)68800-3

Mundy GR, 1991, Ciba Found Symp, 157, 137

10.1097/00008505-199700610-00004

10.1002/jbmr.5650090402

10.1002/jcp.1041430304

10.1002/(SICI)1097-4644(19990101)72:1<151::AID-JCB16>3.0.CO;2-E

10.1210/endo-126-3-1654

10.1002/(SICI)1097-4652(199608)168:2<424::AID-JCP21>3.0.CO;2-1

10.1016/0020-1383(96)89031-0

Schroeder A., 1989, Shigaku-Odontol, 77, 1267

10.1210/endo-122-5-2191

10.1007/BF02556260

10.1016/8756-3282(92)90361-Y

10.1002/(SICI)1097-4636(199602)30:2<145::AID-JBM3>3.0.CO;2-R

10.1002/jbmr.5650100320

10.1111/j.1365-3083.1995.tb03647.x

10.1016/0142-9612(95)96872-W

10.1007/s002239900394

Seyedin S., 1986, J Biol Chem, 261, 5693, 10.1016/S0021-9258(17)38436-3

10.1016/8756-3282(96)00044-0

10.1097/00003086-199408000-00032

10.1016/0952-3278(94)90174-0

Takahashi GW, 1994, Leukemia, 8, 305

10.1002/jbm.820190802

10.1016/0022-3913(85)90435-4

10.1016/0142-9612(96)81417-7

10.1163/156856295X00698

10.1034/j.1600-0501.1996.070416.x